Retraction Note: A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.

Arch Gynecol Obstet

Department of Obstetrics and Gynecology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.

Published: February 2024

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00404-023-07330-z	DOI Listing

Publication Analysis

retraction note

note prospective

prospective double-blind

double-blind randomized

randomized placebo-controlled

placebo-controlled clinical

clinical trial

trial bromocriptin

bromocriptin clomiphene-resistant

clomiphene-resistant patients

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!